Estadístiques de Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review
Visites totals
| views | |
|---|---|
| Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review | 59 |
Visites totals per mes
| views | |
|---|---|
| August 2024 | 8 |
| September 2024 | 5 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Andaluz_wjccm_immu.pdf(legacy) | 23 |
| Andaluz_wjccm_immu.pdf | 6 |
Vistes principals per país
| views | |
|---|---|
| United States | 33 |
| Spain | 8 |
| Japan | 6 |
| Egypt | 3 |
| Ethiopia | 2 |
| Taiwan | 2 |
| Brazil | 1 |
| India | 1 |
| Iran | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ann Arbor | 7 |
| Tokyo | 6 |
| Boardman | 5 |
| Mountain View | 5 |
| San Ramon | 5 |
| Barcelona | 2 |
| Menlo Park | 2 |
| Taipei | 2 |
| Ashburn | 1 |
| Cambridge | 1 |
| Madrid | 1 |
| Mumbai | 1 |
| Nijmegen | 1 |
| Petaling Jaya | 1 |
| Ponferrada | 1 |
| Sacramento | 1 |
| San Diego | 1 |
| São Paulo | 1 |